3,085 results on '"Fareed, Jawed"'
Search Results
2. Absolute pharmacokinetics of heparin in primates
3. Abstract 16961: Characterization of Extracellular Vesicles and RNA Content and Its Relevance to Thrombo-Inflammatory Biomarkers in Patients With Acute Pulmonary Embolism
4. Abstract 16964: Predictive Value of Blood Cellular Indices for 30-day Mortality in Patients With Acute Pulmonary Embolism. Data From the RIETE Registry
5. Severe Hyporesponsiveness to Erythropoiesis-Stimulating Agents in Patients on Chronic Hemodialysis—Reconsidering the Relationship with Thrombo-Inflammation and Oxidative Stress.
6. Rivaroxaban versus no anticoagulation for post-discharge thromboprophylaxis after hospitalisation for COVID-19 (MICHELLE): an open-label, multicentre, randomised, controlled trial
7. Immune activation and inflammatory biomarkers as predictors of venous thromboembolism in lymphoma patients
8. Elevated salivary cortisol predicts response to adjunctive immune modulation in treatment-resistant bipolar depression
9. Abstract 10876: Thrombo-Inflammatory Biomarkers in Pulmonary Embolism as Stratified in Cancer and Non-Cancer Patient Groups
10. Abstract 10655: Collagen Remodeling, Inflammatory Biomarkers and Fatty Acid Regulation in Understanding the Molecular Pathogenesis of Atrial Fibrillation
11. Rivaroxaban for Patients with Intermittent Claudication.
12. The prognostic value of blood cellular indices in pulmonary embolism.
13. Algorithm for Rapid Exclusion of Clinically Relevant Plasma Levels of Direct Oral Anticoagulants in Patients Using the DOAC Dipstick: An Expert Consensus Paper.
14. Catheter-Based Local Delivery of Therapeutics to the Lungs for Severe or Critically Ill Patients with COVID-19
15. Plasma MCP-1 levels in bipolar depression during cyclooxygenase-2 inhibitor combination treatment
16. Structural characterization of a clinically described heparin-like substance in plasma causing bleeding
17. Effects of adjunctive inflammatory modulation on IL-1β in treatment resistant bipolar depression
18. Vascular endothelial growth factor in bipolar depression: A potential biomarker for diagnosis and treatment outcome prediction
19. Prevention and management of venous thromboembolism. International Consensus Statement. Guidelines according to scientific evidence
20. Thromboinflammatory Biomarkers of Cardiorenal Syndrome in Patients With End-Stage Renal Disease
21. Andexanet Alfa Neutralizes the Anticoagulant Effects of Unfractionated Heparin of Bovine, Ovine and Porcine Origin Almost as Protamine Sulfate
22. Biomarkers Profile in Provoked Versus Unprovoked Deep Venous Thrombosis
23. Neurological Complications of Pulmonary Embolism: a Literature Review
24. Anticoagulant activity of porcine heparin: Structural-property relationship and semi-quantitative estimation by nuclear magnetic resonance (NMR) spectrometry
25. Chemometric analysis of porcine, bovine and ovine heparins
26. ENDOTHELIAL DYSREGULATION MEDIATORS IN MEDIATING HEMOSTATIC AND INFLAMMATORY IMBALANCE IN CANCER-ASSOCIATED THROMBOSIS
27. INTERCONNECTION BETWEEN THROMBO-INFLAMMATORY AND OXIDATIVE STRESS-RELATED BIOMARKERS IN PATIENTS WITH NON-SMALL CELL LUNG CANCER
28. Therapeutic efficacy of peptide vaccine (AtheroVax) in an animal model of chronic inflammation
29. Prevalence and outcome of acute pulmonary embolism in hospitalized patients with a history of inflammatory bowel disease
30. Validation of a Gravitational Model to Study Local Endogenous Biomarkers in Chronic Venous Insufficiency
31. Plasma C-reactive protein levels in bipolar depression during cyclooxygenase-2 inhibitor combination treatment
32. Improving reliability of chemometric models for authentication of species origin of heparin by switching from 1D to 2D NMR experiments
33. Authentication of animal origin of heparin and low molecular weight heparin including ovine, porcine and bovine species using 1D NMR spectroscopy and chemometric tools
34. Synthetic, organic compound vepoloxamer (P-188) potentiates tissue plasminogen activator
35. Effect of a Recombinant Human Soluble Thrombomodulin on Baseline Coagulation Biomarker Levels and Mortality Outcome in Patients With Sepsis-Associated Coagulopathy
36. Abstract P3021: Circulating Exosomal MicroRNAs As Biomarkers For Pulmonary Embolism
37. A novel therapeutic vaccine targeting the soluble TNFα receptor II to limit the progression of cardiovascular disease: AtheroVax™
38. Physiology of Hemostasis
39. Looking Forward To The Future of Heparin : New Sources, Developments and Applications
40. Chapter 37 - Cardiometabolic diseases—Recent advance in antithrombotic and thrombolytic therapies
41. How to manage coagulopathy in Klippel–Trenaunay syndrome?
42. To what extent should anticoagulation therapy be considered for venous malformations?
43. Causality Assessment and Examples of Adverse Drug Reactions (Drug-Induced Liver Injury, Renal, Skin, and Major Adverse Cardiac Events)
44. List of Contributors
45. Cleavage of the Antithrombin III Binding Site in Heparin by Heparinases and Its Implication in the Generation of Low Molecular Weight Heparin
46. Abstract 14049: Correlation of Cellular Indices and D-dimer/fibrinogen Ratio to Gender Differences in 6-minute Walk Test Distance in Patients Presenting With Acute Pulmonary Embolism
47. Venous Disorders: Medical Management
48. Lipid Lowering Drugs
49. Antiplatelet Drugs in the Management of Cardiovascular Indications
50. 507. Relationship Between Vascular Endothelial Growth Factor (VEGF) and Peripheral Inflammation Markers in Treatment-Resistant Bipolar Depression Disorder (TRBDD)
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.